Publications by authors named "Michael Pinnolis"

Claim this Profile
F
Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration.
Michael T Andreoli, Michael Pinnolis, Troy Kieser, Jennifer Sun, Christopher M Andreoli

Digit J Ophthalmolยท March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis